Med24
Medical Research 28. 10. 2026 • 2 min read • News Medical

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company specializing in cell preservation using hydrogel encapsulation technology, has partnered with Frontier Space, a UK-based space biotechnology company, to validate Atelerix’s technology for preserving biological samples during space missions. This collaboration focuses on improving sample quality and reducing associated costs within microgravity research. The partnership will assess Atelerix’s patented alginate hydrogel encapsulation technology for ambient temperature preservation and transport of suspended mammalian cells, organoids, and organ-on-chip models. This approach aims to address key bottlenecks in microgravity research by simplifying sample transport and handling, reducing preservation-related payload mass and risk, and evaluating sample integrity for post-flight analysis. The companies intend to remove reliance on cold-chain logistics, a significant operational complexity and risk factor. Frontier Space provides in-space R&D services, leveraging microgravity conditions to enhance protein crystallization, 3D cell culture, and accelerated ageing. The agreement outlines Atelerix’s provision of preservation products, protocols, and technical support, while Frontier Space will identify relevant use cases, support design and execution of validation work, and integrate the technology within its in-space R&D capabilities. Launch opportunities are targeted throughout 2027. The collaboration seeks to improve access to pharmaceutical research in orbit by making space-based missions more practical and cost-effective. The parties believe that the technology can reduce reliance on bulky cryogenic storage while maintaining sample quality for post-flight analysis. This partnership represents a route to test the benefits of the approach for microgravity research.

Sponsored content

Original Scientific Source
News Medical
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement